Winton Group LTD Arcturus Therapeutics Holdings Inc. Transaction History

Winton Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$17.71 - $32.97 $58,124 - $108,207	-3,282 Reduced 22.37%	11,389 $359,000
Q3 2023 Nov 13, 2023	BUY	$25.44 - $37.35 $131,372 - $192,875	5,164 Added 54.32%	14,671 $374,000
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $227,597 - $307,646	9,507 New	9,507 $272,000
Q4 2021 Feb 10, 2022	SELL	$34.2 - $47.56 $159,474 - $221,772	-4,663 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$27.88 - $58.25 $181,247 - $378,683	-6,501 Reduced 58.23%	4,663 $223,000
Q2 2021 Aug 10, 2021	BUY	$25.79 - $42.11 $12,895 - $21,055	500 Added 4.69%	11,164 $378,000
Q1 2021 Jul 21, 2021	BUY	$38.75 - $86.92 $413,230 - $926,914	10,664 New	10,664 $440,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.